Related Experiment Video
Updated: Mar 27, 2026

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
Published on: April 9, 2012
Pulmonary tuberculosis: Improving diagnosis and management
1Stacey Singer-Leshinsky is an associate professor at St. John's University in Queens, N.Y. The author has disclosed no potential conflicts of interest, financial or otherwise.
Tuberculosis (TB) is a significant global health threat. Early identification and updated treatment strategies for drug-sensitive and drug-resistant tuberculosis are crucial for reducing transmission and improving patient outcomes.
Area of Science:
- Medicine
- Infectious Diseases
- Public Health
Background:
- Tuberculosis (TB) remains a leading cause of infectious disease mortality globally.
- Emerging drug-resistant strains and increasing immunocompromised populations heighten the need for clinical vigilance.
- Familiarity with TB's presentation is essential for effective patient management.
Purpose of the Study:
- To provide a comprehensive review of tuberculosis.
- To highlight recent advancements in the treatment of both drug-sensitive and drug-resistant TB.
- To emphasize the importance of early diagnosis and management in reducing TB transmission and mortality.
Main Methods:
- Review of current literature on tuberculosis pathology, clinical presentation, diagnostics, and management.
- Focus on recent therapeutic advances for drug-sensitive and drug-resistant tuberculosis.
- Synthesis of information to guide clinical practice.
Main Results:
- Tuberculosis presents diverse clinical manifestations requiring thorough diagnostic evaluation.
- Advances in pharmacotherapy offer improved treatment options for various forms of TB.
- Effective management strategies are critical for preventing complications and reducing disease burden.
Conclusions:
- Enhanced understanding of TB pathology and clinical signs aids early detection.
- Updated treatment protocols for drug-sensitive and drug-resistant TB are vital for patient recovery.
- Timely intervention and comprehensive care are key to reducing TB morbidity and mortality worldwide.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

